LB Pharmaceuticals shares rise nearly 27% giving biotech valuation of about $382 million-March 2024-www.financetom.com

LB Pharmaceuticals shares rise nearly 27% giving biotech valuation of about $382 million

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

LB Pharmaceuticals shares rise nearly 27% giving biotech valuation of about $382 million

Sep 11, 2025 9:34 AM

Sept 11 (Reuters) - LB Pharmaceuticals' shares

rose 27% in their Nasdaq debut on Thursday, giving the biotech

firm a valuation of $381.9 million and opening the door for

similarly hopeful companies as the IPO fall market heats up.

Previous page： NANO Nuclear Signs Letter of Intent with Cambridge Atom Works to Sell its Portable ODIN™ Reactor Technology Next page： DeFi Development Corp. Acquires $15M of SOL

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

NANO Nuclear Signs Letter of Intent with Cambridge Atom Works to Sell its Portable ODIN™ Reactor Technology

Sep 17, 2025

Sale of the low-pressure coolant ODIN™ enables NANO Nuclear to sharpen focus on its portfolio of gas-cooled technologies — KRONOS MMR™, LOKI MMR™, and ZEUS™ — and maximize developmental and regulatory efficiencies and long-term commercial advancement. New York, N.Y., Sept. 17, 2025 (GLOBE NEWSWIRE) -- NANO Nuclear Energy Inc. ( NNE ) (“Nano Nuclear” or the “Company”), a leading advanced...

DeFi Development Corp. Acquires $15M of SOL

Sep 17, 2025

BOCA RATON, FL, Sept. 17, 2025 (GLOBE NEWSWIRE) -- DeFi Development Corp. ( DFDV ) (the “Company”) the first public company with a treasury strategy built to accumulate and compound Solana (“SOL”), today announced the acquisition of 62,745 SOL. This purchase brings the Company’s total holdings to 2,095,748 SOL, valued at approximately $499 million. Below is a summary of DeFi...

BRIEF-WNS And Capgemini Obtain All Antitrust And Regulatory Approvals

Sep 17, 2025

Sept 17 (Reuters) - WNS (HOLDINGS) ( WNS ): * WNS AND CAPGEMINI OBTAIN ALL ANTITRUST AND REGULATORY APPROVALS * WNS UPDATES PROGRESS ON ACQUISITION BY CAPGEMINI Source text: Further company coverage: ...

Twilio Seeing Messaging Momentum, AI Voice Opportunity as Core Risks Remain, RBC Says

Sep 17, 2025

11:47 AM EDT, 09/17/2025 (MT Newswires) -- Twilio ( TWLO ) is expected to sustain growth driven by messaging and artificial intelligence-driven voice services, but continues to face margin pressures, increasing competition, and execution risks, RBC Capital Markets said in a note Monday. Analysts said they came away from a group call with Twilio ( TWLO ) management and investors...